Clinical Trial Update: Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple Sclerosis [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating the efficacy and safety of dronabinol for central neuropathic pain in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Neuropathic Pain
• Multiple Sclerosis

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

Sponsor: Bionorica Research GmbH | Conditions: Central Neuropathic Pain in Multiple Sclerosis | Phase 3 | Status: COMPLETED